🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Norwegian Mycelium AS bags €1.25m to scale mycoprotein production european-biotechnology.com/latest-news/no… Foodtech startup Norwegian Mycelium A/S has raised €1.25m in a financing round led by Nippon Beet Sugar Manufacturing Co., Ltd. (Nitten), Japan’s largest beet sugar producer, to sc...

EU set to improve investment for biotech start-ups and scale-ups european-biotechnology.com/latest-news/eu… The European Commission has promised to create a new public-private fund to bridge the ‘valley of death’ phase for technology companies facing expansion. In addition, the EU wants t...

Scientists uncover target to stop colitis-induced colorectal cancer european-biotechnology.com/latest-news/sc… German researchers have identified a promising new target to stop the inflammatory response in ulcerative colitis—a breakthrough that could help prevent the progression to colorec...

Scotland’s bioeconomy gets scale-up boost european-biotechnology.com/latest-news/sc… Scotland’s biotechnology sector is celebrating a major milestone with the launch of the nation’s first open-access 300-litre fermenter – a state-of-the-art piece of equipment that will support early-stage ...

Super deal for BioNTech – BMS licenses potential blockbuster for €10bn european-biotechnology.com/latest-news/su… In the race to replace MSD's mega blockbuster pembrolizumab with a more effective bispecific VEGF x PD-(L)1 antibody, German company BioNTech SE has struck a good deal. BioNTec...

Pharma industry calls EU pharma package counterproductive european-biotechnology.com/latest-news/ph… Pharmaceutical associations have responded with sharp criticism to the adoption of the revised general pharmaceutical legislation by the EU Council of Ministers in the form of a directive a...

Big deal: Amphistar goes transatlantic european-biotechnology.com/latest-news/bi… Belgian micriobial fermentation specialist AmphiStar NV has partnered with US plant-based ingredient heavyweight Kensing to market its biosurfactants in the US, using locally-produced feedstocks. Amphistar's ...

Spanish BIO-CAT cluster starts new ATMP accelerator european-biotechnology.com/latest-news/sp… The Spanish BIO-CAT cluster has launched a new accelerator called ATMP Catalyst, which will support six preclinical gene and cell therapy projects per year in each of three annual calls to suppor...

Mosanna Therapeutics NV bags $80m in Series A round european-biotechnology.com/latest-news/mo… Dutch obstructive sleep apnea (OSA) specialist Mosanna Therapeutics NV has secured US$80m in a Series A financing to fund clinical testing through Phase II of its nasal OSA spray MOS118.

SpliceBio SL secures US$135m in Series B financing european-biotechnology.com/latest-news/sp… SpliceBio SL has baged US$135m in a Series B financing co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors The Barcelona-...

The smell of food makes you feel full european-biotechnology.com/latest-news/th… Lose weight without expensive obesity pills? The discovery of a direct link between olfactory receptors and areas of the brain that signal satiety makes this seem possible, initially in mice.

GEA to open food biotech pilot-scale facility in USA european-biotechnology.com/latest-news/ge… GEA has launched its second Food Application and Technology Center (ATC) globally in the US, to target the largest consumer market for cellular agriculture. The facility features advanced biorea...

French Afyren starts production of bio-acids – CEO in interview european-biotechnology.com/latest-news/fr… AFYREN, a French greentech company focused on sustainable, bio-based industrial solutions, has achieved a major milestone with the successful launch of continuous production at its ...

Afyren SA launches continuous production at first biorefinery european-biotechnology.com/latest-news/af… French green-tech company Afyren SA (Clermont-Ferrand) has begun continuous production of biobased chemical building blocks at its first biorefinery, Afyren NEOXY, marking a major miles...

Mabion launches €500,000 services contest to support oncology breakthroughs  european-biotechnology.com/latest-news/ma… Lodz-based CDMO Mabion SA has launched a €500,000 oncology services contest at BIO International Convention 2025, aimed at accelerating the development of recombinant pr...

Rapid progress in cultivated meat european-biotechnology.com/latest-news/ra… Cultivated meat is expected to reach price parity with conventional meat sooner than previously forecast, according to a new analysis by technology foresight specialist GetFocus.

Cellular Origines partners with Johnson & Johnson european-biotechnology.com/latest-news/ce… British gene and cell therapy manufacturing specialist Cellular Origins Ltd has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform for autologo...

Italy and Germany block central green deal legislation european-biotechnology.com/latest-news/it… The European Commission has scraped a key piece of Green Deal legislation following political shifts within the European Parliament. The move came after Italy, governed by a far-right administ...

Sonrai and Plectonic Biotech partner to advance cancer immunotherapies european-biotechnology.com/latest-news/so… Under a new partnership, Plectonic Biotech will use Sonrai’s AI-powered multi-omics platform to speed up development of its Logybody cancer treatment technology. The approach a...

Industry veteran has joined board of directors european-biotechnology.com/latest-news/in… Italian Sibylla Biotech has appointed a new Chairman of the Board of Directors: Dieter Weinand, former President, CEO and Chairman of the Board of Bayer Pharmaceuticals AG.